Search - tctmd.com

Displaying 461 - 480 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

Stent Embolizations

Presenter: Dimitri Karmpaliotis, Emmanouil S. Brilakis

October 30, 2016

Presentation TCT 2016

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Runlin Gao

October 30, 2016

Presentation TCT 2016

Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions Is Sufficient

Presenter: Mohamed Abdel-Wahab, Philippe Généreux

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Ashok Seth

October 30, 2016

Presentation TCT 2016

A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures

Presenter: Mark Reisman, Josep Rodés-Cabau, Danny Dvir

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

Presentation TCT 2016

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

News Industry News

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

October 30, 2016

News Industry News

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

October 30, 2016

Presentation TCT 2016

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, David E. Kandzari

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy Clinical Trial Design

Presenter: C. Michael Gibson, Daniel I. Simon, Sanjay Kaul

October 30, 2016

Presentation TCT 2016

A Novel System to Save Contrast During Coronary Angiography: The DyeVert Randomized Controlled Study

Presenter: Lawrence A. Garcia, Jihad A. Mustapha, Steffen Desch

October 30, 2016

Presentation TCT 2016

DES Systems and Outcomes

Presenter: Bonnie H. Weiner, Jose M. Wiley, Gennaro Sardella

October 29, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

Advertisement

Stent Embolizations

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions Is Sufficient

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Limitations of Pharmacotherapy Clinical Trial Design

A Novel System to Save Contrast During Coronary Angiography: The DyeVert Randomized Controlled Study

DES Systems and Outcomes

TCTMD’s Top 10 Most Popular Stories for October 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content